课题基金 / 基金详情

Dissection of alpha mannosidases: from reaction coordinate to inhibition

Dissection of alpha mannosidases: from reaction coordinate to inhibition
α甘露糖苷酶剖析:从反应坐标到抑制
批准号:
BB/G016127/1
负责人:
Gideon Davies
金额:
$68.96万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2009
资助国家:
英国
项目状态:
已结题
起止时间:
2009 至 --

项目摘要

项目成果

Gideon Davies的其他基金

相似基金

相关文献

中文摘要
翻译
糖不仅仅是食物。糖类覆盖着我们所有的细胞和病原体的细胞。细胞之间的通讯,无论是健康的还是致病的,正常的和肿瘤的都是由糖控制的。糖是“细胞的语言”。制造、修饰和调节糖的化工厂被称为“酶”。这些酶机器的控制和组织是健康有机体的核心,反过来,它们的颠覆会导致细胞生长、自身免疫性疾病和癌症的变化。科学家们对一种名为甘露糖的不同寻常的糖特别感兴趣,因为它的化学非常困难(其拥挤的中心使反应变得困难),而且参与其修饰的酶既非常不寻常,又与细胞分裂和疾病有关。这笔BBSRC赠款的目的是研究参与甘露糖化学的酶,在三维水平上剖析它们,然后使用巧妙的化学来研究它们的反应,并激发和分析抑制物,这些抑制物应该导致健康细胞和潜在的治疗药物的化学探针。
英文摘要
Sugars are more than just food. Sugars coat all our cells and the cells of our pathogens. The communication between cells, both healthy and pathogenic, both normal and tumour is governed by sugars. Sugars are 'the language of the cell'. The chemical factories that make, modify and tune sugars are called 'enzymes'. The control and organisation of these enzymatic machines is central to the healthy organism and, conversely, their subversion leads to changes in cell growth, auto immune disease and cancers. An unusual sugar, called mannose, is of particular interest to scientists as its chemistry is very difficult (its crowded centres make reactions difficult) and because the enzymes involved in its modification are both highly unusual and implicated in cell division and disease. The aim of this BBSRC grant is to study enzymes involved in mannose chemistry, to dissect them at the three-dimensional level and then to use cunning chemistry to both study their reaction and inspire and analyse inhibitors that should lead to chemical probes of healthy cells and potential therapeutic agents.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Fleetamine (3-O-a-d-glucopyranosyl-swainsonine): the synthesis of a hypothetical inhibitor of endo-a-mannosidase
Fleetamine(3-O-a-d-吡喃葡萄糖基-苦豆素):合成一种假设的内切-α-甘露糖苷酶抑制剂
DOI: 10.1016/j.tetasy.2012.06.011
发表时间: 2012
期刊: Asymmetry
影响因子: --
作者: [Quach T]
通讯作者: Quach T
DOI: 10.1371/journal.pone.0009006
发表时间: 2010-02-03
期刊: PloS one
影响因子: 3.7
作者: [Suits MD, Zhu Y, Taylor EJ, Walton J, Zechel DL, Gilbert HJ, Davies GJ]
通讯作者: Davies GJ
Exploring New Pathways of Sulfoquinovose degradation in the biosphere
  • 批准号:
    BB/W003805/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $59.85万
  • 财政年份:
    2022
  • 负责人:
    Gideon Davies
  • 依托单位:
Dissection of the Leishmania mannogen biosynthetic pathway: beta 1-2 mannan in pathogens and beyond
  • 批准号:
    BB/T004819/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $58.9万
  • 财政年份:
    2020
  • 负责人:
    Gideon Davies
  • 依托单位:
X-ray Diffraction Equipment for Macromolecular Crystallography at York
  • 批准号:
    BB/T017805/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $95.56万
  • 财政年份:
    2020
  • 负责人:
    Gideon Davies
  • 依托单位:
Application of activity-based glycosidase probes for mechanism, enzyme discovery and clinical diagnosis
  • 批准号:
    BB/R001162/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $92.86万
  • 财政年份:
    2018
  • 负责人:
    Gideon Davies
  • 依托单位:
国内基金
海外基金
基于PTEN/Akt1/HIF-1alpha通路探讨六仁通便汤改善功能性便秘的机制
  • 批准号:
    2025JJ81110
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    喻融
  • 依托单位:
人源alpha2肾上腺素受体偏向激活机制及活性药物发现
  • 批准号:
    82574379
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    杜洋
  • 依托单位:
Vdelta2-T细胞外泌体疫苗携带IFN-gamma和TNF-alpha诱导抗原提呈细胞成熟并促进EBV肿瘤免疫应答的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    王系伟
  • 依托单位:
氘氚等离子体中alpha粒子输运的集成模拟研究
  • 批准号:
    12475216
  • 项目类别:
    面上项目
  • 资助金额:
    53.00万元
  • 批准年份:
    2024
  • 负责人:
    郝保龙
  • 依托单位: